Charm Therapeutics raised $80M Series B round co-led by New Enterprise Associates and SR One, w/ OrbiMed, F-Prime Capital, Khosla Ventures, and NVIDIA
02 August 2025
02 August 2025
Total investments received (USD): 130M
Round value (USD): 80M
Company: Charm Therapeutics
Related deals
PolyAI raised $86 million in Series D funding round co-led by Georgian, Hedosophia and Khosla Ventures, joined by Sands Capital, Squarepoint, Citi, Point72
Investments
03 December 2025
Runware raised $50m in Series A funding led by Dawn Capital, joined by Comcast Ventures, Speedinvest, Insight Partners and a16z Speedrun.
Investments
01 December 2025
Model ML in a $75M series A led by FT Partners with participation from Y Combinator, QED, 13Books, Latitude and LocalGlobe.
Investments
12 November 2025
Chemify raised $50 million Series B round led by Insight Partners and Wing.
Investments
10 October 2025
Comind to raise $60M series B led by Plural, joined by Angelini, LocalGlobe, Octopus Ventures, Crane Venture Partners, BACKED VC and Entrepreneurs First.
Investments
09 October 2025
Belgium
Netherlands
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Portugal
Spain